IFNγ production and cytotoxicity have been considered two distinctive functions of different NK subsets (31, 32), but growing evidence shows that the main cytotoxic NK subset, CD56dimCD16+ NK cells, that are responsible for mAb-mediated tumor killing, are also able to produce IFNγ following activation (33, 34). The gene discussed is IFNG; the disease is neoplasm.